Views & Analysis Sponsored Media means business COVID-19 has left us more reliant on media than ever – both the pharma industry and society as a whole.
Views & Analysis Emotional empathy is driving brand equity How the COVID-19 pandemic is forging pharmaceutical brands into better shape.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
